262 related articles for article (PubMed ID: 25025965)
1. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.
Souchek JJ; Baine MJ; Lin C; Rachagani S; Gupta S; Kaur S; Lester K; Zheng D; Chen S; Smith L; Lazenby A; Johansson SL; Jain M; Batra SK
Br J Cancer; 2014 Sep; 111(6):1139-49. PubMed ID: 25025965
[TBL] [Abstract][Full Text] [Related]
2. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling.
Seshacharyulu P; Halder S; Nimmakayala R; Rachagani S; Chaudhary S; Atri P; Chirravuri-Venkata R; Ouellette MM; Carmicheal J; Gautam SK; Vengoji R; Wang S; Li S; Smith L; Talmon GA; Klute K; Ly Q; Reames BN; Grem JL; Berim L; Padussis JC; Kaur S; Kumar S; Ponnusamy MP; Jain M; Lin C; Batra SK
EBioMedicine; 2022 Jan; 75():103772. PubMed ID: 34971971
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition.
Jonsson M; Ragnum HB; Julin CH; Yeramian A; Clancy T; Frikstad KM; Seierstad T; Stokke T; Matias-Guiu X; Ree AH; Flatmark K; Lyng H
Br J Cancer; 2016 Oct; 115(8):929-939. PubMed ID: 27599042
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1.
Kijima T; Koga F; Fujii Y; Yoshida S; Tatokoro M; Kihara K
PLoS One; 2013; 8(5):e64615. PubMed ID: 23741352
[TBL] [Abstract][Full Text] [Related]
5. Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells.
Ishimoto K; Tachibana K; Hanano I; Yamasaki D; Nakamura H; Kawai M; Urano Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T
Biochem J; 2010 Jul; 429(2):347-57. PubMed ID: 20450493
[TBL] [Abstract][Full Text] [Related]
6. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
7. Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells.
Ory B; Moriceau G; Trichet V; Blanchard F; Berreur M; Rédini F; Rogers M; Heymann D
J Cell Mol Med; 2008 Jun; 12(3):928-41. PubMed ID: 18494934
[TBL] [Abstract][Full Text] [Related]
8. Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer.
Nguyen L; Dobiasch S; Schneider G; Schmid RM; Azimzadeh O; Kanev K; Buschmann D; Pfaffl MW; Bartzsch S; Schmid TE; Schilling D; Combs SE
Radiother Oncol; 2021 Jun; 159():265-276. PubMed ID: 33839203
[TBL] [Abstract][Full Text] [Related]
9. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.
Seshacharyulu P; Rachagani S; Muniyan S; Siddiqui JA; Cruz E; Sharma S; Krishnan R; Killips BJ; Sheinin Y; Lele SM; Smith LM; Talmon GA; Ponnusamy MP; Datta K; Batra SK
Oncogene; 2019 Jun; 38(26):5265-5280. PubMed ID: 30914801
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma.
Kim EH; Kim MS; Lee KH; Koh JS; Jung WG; Kong CB
Oncotarget; 2016 Oct; 7(43):70869-70880. PubMed ID: 27765919
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells.
Wang P; Zhang J; Zhang L; Zhu Z; Fan J; Chen L; Zhuang L; Luo J; Chen H; Liu L; Chen Z; Meng Z
Gastroenterology; 2013 Nov; 145(5):1133-1143.e12. PubMed ID: 23916944
[TBL] [Abstract][Full Text] [Related]
12. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
13. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
[TBL] [Abstract][Full Text] [Related]
14. S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells.
Kozono S; Ohuchida K; Ohtsuka T; Cui L; Eguchi D; Fujiwara K; Zhao M; Mizumoto K; Tanaka M
Oncol Rep; 2013 Oct; 30(4):1601-8. PubMed ID: 23900547
[TBL] [Abstract][Full Text] [Related]
15. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer.
Kern J; Schilling D; Schneeweis C; Schmid RM; Schneider G; Combs SE; Dobiasch S
Radiother Oncol; 2024 Feb; 191():110059. PubMed ID: 38135186
[TBL] [Abstract][Full Text] [Related]
16. Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
Idrees AS; Sugie T; Inoue C; Murata-Hirai K; Okamura H; Morita CT; Minato N; Toi M; Tanaka Y
Cancer Sci; 2013 May; 104(5):536-42. PubMed ID: 23387443
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines.
Sangar VK; Cowan R; Margison GP; Hendry JH; Clarke NW
Br J Cancer; 2004 Jan; 90(2):542-8. PubMed ID: 14735206
[TBL] [Abstract][Full Text] [Related]
18. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
19. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
[TBL] [Abstract][Full Text] [Related]
20.
Wang F; Xia X; Yang C; Shen J; Mai J; Kim HC; Kirui D; Kang Y; Fleming JB; Koay EJ; Mitra S; Ferrari M; Shen H
Clin Cancer Res; 2018 Jul; 24(13):3176-3185. PubMed ID: 29602802
[No Abstract] [Full Text] [Related]
[Next] [New Search]